| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/18/2006 | US7029665 Human suppressor tRNA oligonucleotides and methods for use for same |
| 04/18/2006 | US7029664 Chicken leukemia inhibitory factor (LIF) |
| 04/18/2006 | CA2252505C New antigen presenting cells, a process for preparing the same and their use as cellular vaccines |
| 04/13/2006 | WO2006039701A1 Flagellin-based adjuvants and vaccines |
| 04/13/2006 | WO2006039678A2 Establishment of highly metastatic cell lines using nog mice |
| 04/13/2006 | WO2006039671A2 Gene markers of tumor metastasis |
| 04/13/2006 | WO2006039604A1 Use of pregnancy specific glycoprotein for maturation of oocytes |
| 04/13/2006 | WO2006039592A1 Use of il-17- for maturation of oocytes |
| 04/13/2006 | WO2006039582A2 Compositions and methods for diagnosing and treating brain cancer and identifying neural stem cells |
| 04/13/2006 | WO2006039484A2 Method for chondrocyte expansion with phenotype retention |
| 04/13/2006 | WO2006039418A2 Human monoclonal antibodies to fc gamma receptor ii (cd32) |
| 04/13/2006 | WO2006038729A1 Mutated amyloid protein |
| 04/13/2006 | WO2006038462A1 Novel steroid-producing cell |
| 04/13/2006 | WO2006038405A1 Cell treatment method and cell treatment equipment |
| 04/13/2006 | WO2006037947A1 Synthetase enzymes |
| 04/13/2006 | WO2006037762A1 Method for ex-vivo purging in autologous transplantation |
| 04/13/2006 | WO2006037657A2 Quadruple transformed cell line useful for the identification of transport inhibitors |
| 04/13/2006 | WO2006037649A1 Identification and insolation of multipotent cells from non-osteochondral mesenchymal tissue |
| 04/13/2006 | WO2006037579A1 Use of fibroblasts differentiating in fat cells, bone cells and cartilage cells |
| 04/13/2006 | WO2006037328A1 Polypeptides having phytase activity and polynucleotides encoding same |
| 04/13/2006 | WO2006037224A1 Isolated clk-1 -i- cells from clk-1 heterozygous animals and their use in treating oxidative stress disorders |
| 04/13/2006 | WO2006037215A1 Expression system, components thereof and methods of use |
| 04/13/2006 | WO2006018849A3 Non-invasive prenatal genetic diagnosis using transcervical cells |
| 04/13/2006 | WO2006012837A3 Graft structure comprising terminally differentiated tissue cells for the reconstruction of an organ |
| 04/13/2006 | WO2006011795A3 Method for preventing dehiscence and altering plant lignification |
| 04/13/2006 | WO2006008401A3 Composition containing a photosynthetic marine and/or fresh-water microorganism culture medium and/or |
| 04/13/2006 | WO2006005802A8 Method for stimulating mammalian cells and mammalian cell |
| 04/13/2006 | WO2005116199A3 Tobacco nicotine demethylase genomic clone and uses thereof |
| 04/13/2006 | WO2005116192A3 Genetically engineered cells for therapeutic applications |
| 04/13/2006 | WO2005095632A3 Methods for identifying proteins with starch phosphorylating enzymatic activity |
| 04/13/2006 | WO2005079145A8 Tissue system with undifferentiated stem cells derived from corneal limbus |
| 04/13/2006 | WO2005032460A3 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 04/13/2006 | US20060080750 Nucleic acid constructs and methods for producing altered seed oil compositions |
| 04/13/2006 | US20060080745 Gene reactivation by somatic hypermutation |
| 04/13/2006 | US20060079675 Compositions and use of inflammation-20 (Inf-20) gene |
| 04/13/2006 | US20060079670 98 human secreted proteins |
| 04/13/2006 | US20060079451 Heparin-binding proteins modified with sugar chains, method of producing the same and pharmaceutical compositions containing same |
| 04/13/2006 | US20060078995 Method of using fish plasma components for tissue engineering |
| 04/13/2006 | US20060078994 Mature dendritic cell compositions and methods for culturing same |
| 04/13/2006 | US20060078993 Isolation, cultivation and uses of stem/progenitor cells |
| 04/13/2006 | US20060078992 protein biosynthesis inhibitor resistance genes capable of imparting cycloheximide resistance to animal cells sensitive to the inhibitor; genes have sequences mutated by substitution in a gene coding a ribosome-constituting protein derived from an animal; expression vectors; genetic engineering |
| 04/13/2006 | US20060078991 host cells into which a gene encoding an antibody is introduced, which is resistant to a section which recognizes a sugar chain in which fucose is bound to N-acetylglucosamine in a complex N-glycoside-linked sugar chain; antibodies used for diseases having antibody-dependent cell-mediated cytotoxicity |
| 04/13/2006 | US20060078990 antibodies comprising complex N-glycoside-linked sugar chains bound to the Fc fragments, having reduced levels of fucose bound to N-acetylglucosamine; antibodies with increased antibody-dependent cellular cytotoxicity; fusion proteins |
| 04/13/2006 | US20060078989 Dedifferentiated, programmable stem cells of monocytic origin, and their production and use |
| 04/13/2006 | US20060078981 Reducing branching and enhancing fragmentation in culturing filamentous microorganisms |
| 04/13/2006 | US20060078969 Regulated transcription of targeted genes and other biological events |
| 04/13/2006 | US20060078967 Antibodies for IL-17 receptor like polypeptides and uses thereof |
| 04/13/2006 | US20060078965 Chinese hamster ovary cell line transfected with 30K gene |
| 04/13/2006 | US20060078963 Methods for producing modified glycoproteins |
| 04/13/2006 | US20060078961 Microfluidic systems for altering the solution environment around a nanoscopic or microscopic object, such as a sensor; applied in any sensor technology in which the sensing element needs to be exposed rapidly, sequentially, and controllably, to a large number of different solution environments |
| 04/13/2006 | US20060078951 Monoclonal antibody selectively recognizing listeria monocytogenes, hybridoma producing the antibody, test kit comprising the antibody and detection method of listeria monocytogenes using the antibody |
| 04/13/2006 | US20060078946 Method for manufacturing antigen-specific antibody-producing hybridomas employing a single antigen-specific B lymphocyte and method for manufacturing monoclonal antibody |
| 04/13/2006 | US20060078945 Complex formed by N-linked glycoproteins (SIBLINGS) and Factor H |
| 04/13/2006 | US20060078909 Novel sulfurylase-luciferase fusion proteins and thermostable sulfurylase |
| 04/13/2006 | US20060078901 Listeria monocytogenes genome, polypeptides and uses |
| 04/13/2006 | US20060078879 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications |
| 04/13/2006 | US20060078878 Cell containing nucleic acid molecule comprising polynucleotide sequence encoding engineered zinc finger protein operably linked to promoter, contacting target site in endogenous cellular gene with protein to inhibit transcription |
| 04/13/2006 | US20060078876 Determining an antioxidant deficiency in a lymphocyte by determining a level of intracellular cysteine in the lymphocyte by measuring lymphocyte growth in a serum-free medium comprising cumene hydroperoxide and N-acetyl-L-cysteine and correlating the lymphocyte growth with the antioxidant deficiency. |
| 04/13/2006 | US20060078875 Genetic selection of small molecule modulators of protein-protein interactions |
| 04/13/2006 | US20060078552 Hybrid and single chain meganucleases and use thereof |
| 04/13/2006 | US20060078545 Neural progenitor cell populations |
| 04/13/2006 | US20060078544 generating an enhanced immune response to a prostate tumor associated antigen by administering a composition comprising allogeneic cancer cells that have been rendered proliferation-incompetent and have been genetically engineered to express granulocyte-macrophage colony stimulating factor (GM-CSF) |
| 04/13/2006 | US20060078543 Neural progenitor cells derived from embryonic stem cells |
| 04/13/2006 | US20060078540 Dendritic cell nodes |
| 04/13/2006 | DE19953424B4 Verfahren und Anordnung zur Charakterisierung und Vereinzelung von multizellulären Sphäroiden Method and apparatus for characterization and isolation of multicellular spheroids |
| 04/13/2006 | DE10317400B4 EX-VIVO-Hautorganmodell aus Schweinehaut EX VIVO skin organ model from pig skin |
| 04/13/2006 | DE102004049758A1 Polymeres Substrat zur Kultivierung von Zellen, insbesondere von Keratinozyten Polymeric substrate for the cultivation of cells, especially keratinocytes |
| 04/13/2006 | DE102004049757A1 Open-pored, enzymatically resorbable substrate for cell culture, useful e.g. for treating chronic wounds and in tissue engineering, is prepared from a mixture of polypeptides, crosslinking agent and surfactant |
| 04/13/2006 | DE102004048462A1 Modellsystem zum Testen von pharmazeutischen Zubereitungen auf Wirksamkeit bei entzündlichen Prozessen im Nervensystem Model system to test pharmaceutical preparations for efficacy in inflammatory processes in the nervous system |
| 04/13/2006 | DE102004047965A1 Kryoeinrichtung und zugehöriges Betriebsverfahren Cryoapparatus and operating method thereof |
| 04/13/2006 | CA2610106A1 Polypeptides having phytase activity and polynucleotides encoding same |
| 04/13/2006 | CA2583431A1 Variant amyloid protein |
| 04/13/2006 | CA2583151A1 Identification and insolation of multipotent cells from non-osteochondral mesenchymal tissue |
| 04/13/2006 | CA2582963A1 T-cell receptors containing a non-native disulfide interchain bond linked to therapeutic agents |
| 04/13/2006 | CA2582216A1 Method for ex-vivo purging in autologous transplantation |
| 04/13/2006 | CA2581554A1 Hepatitis c virus replication system |
| 04/13/2006 | CA2581048A1 Use of pregnancy specific glycoprotein for maturation of oocytes |
| 04/13/2006 | CA2580967A1 Irta-4 antibodies and their uses |
| 04/13/2006 | CA2580515A1 Expression system, components thereof and methods of use |
| 04/13/2006 | CA2578573A1 Use of il-17- for maturation of oocytes |
| 04/13/2006 | CA2577006A1 Synthetase enzymes |
| 04/12/2006 | EP1645878A2 Devices and methods for cell harvesting |
| 04/12/2006 | EP1645635A2 Replication defective recombinant retroviruses expressing a palliative |
| 04/12/2006 | EP1645634A2 Transgenic animal models for cardiac hypertrophy and uses thereof |
| 04/12/2006 | EP1645629A1 Human osteoclast-specific and related genes |
| 04/12/2006 | EP1645627A1 Quadruple transformed cell line useful for the identification of transport inhibitors |
| 04/12/2006 | EP1645626A1 Cell line |
| 04/12/2006 | EP1645625A2 Polymer Substrat for Cell Cultivation, Especially Keratinocyte Cultivation |
| 04/12/2006 | EP1645624A1 Nerve cells obtained by electrical pulse treatment es cell |
| 04/12/2006 | EP1645567A1 Lawsonia intracellularis cultivation, anti-Lawsonia intracellularis vaccines and diagnostic agents |
| 04/12/2006 | EP1644514A2 Thermostable amylase polypeptides, nucleic acids encoding those polypeptides and uses thereof |
| 04/12/2006 | EP1644502A2 Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize |
| 04/12/2006 | EP1644491A2 Adenoviral e1a/e1b complementing cell line |
| 04/12/2006 | EP1644490A2 Transgenic cells |
| 04/12/2006 | EP1644489A2 Novel immune booster compound, compositions comprising the same and methods using said booster compound |
| 04/12/2006 | EP1644488A1 Irradiated osteoinductive extracellular material |
| 04/12/2006 | EP1644487A1 Regulatory t-cells containing galectins for the therapy and diagnosis of diseases |
| 04/12/2006 | EP1644486A2 NOVEL METHOD FOR THE PREPARATION OF EMBRYOID BODIES (EBs) AND USES THEREOF |
| 04/12/2006 | EP1644485A2 Secreted proteins as markers for cell differentiation |
| 04/12/2006 | EP1644484A1 Autologous self-tolerance inducing cells of monocytic origin and their use in pharmaceutical proparations |